Cardiovascular (CV) Safety in Type 2 Diabetes: Addressing Patient Safety and Regulatory Requirements
Therapies to treat Type 2 diabetes must demonstrate adequate cardiovascular safety before marketing approval.
PPD’s diabetes team has extensive experience addressing how to best meet the regulatory requirements with time and cost efficiency. The case studies and white papers in this section outline some of the best practices for addressing CV outcomes studies in diabetes trials.
PPD Diabetes Focus Resources:
| White Papers